Drug Shortage Prevention Act of 2025

# Drug Shortage Prevention Act of 2025 - Summary **What the Bill Would Do:** The Drug Shortage Prevention Act of 2025 is designed to address shortages of medications available in the United States. While specific provisions aren't detailed in the available information, bills with this title typically aim to improve the FDA's ability to prevent and respond to drug shortages, increase transparency in the supply chain, and ensure patients have consistent access to necessary medications. The bill would likely establish new requirements for drug manufacturers to report potential supply problems early. **Who It Affects:** This bill would impact patients who depend on medications, pharmaceutical manufacturers and distributors, hospitals and pharmacies, and the FDA.

Healthcare providers and patients have been increasingly affected by drug shortages in recent years, particularly for critical medications, chemotherapy drugs, and other essential treatments. **Current Status:** The bill (S 2665) was introduced in the 119th Congress by Senator Amy Klobuchar (D-Minnesota) and is currently in committee, meaning it has not yet been voted on by the full Senate. The bill has not advanced further at this time.